Itraconazole
Onmel, Sporanox, Tolsura (itraconazole) is a small molecule pharmaceutical. Itraconazole was first approved as Onmel on 1992-09-11. It is used to treat aids-related opportunistic infections, aspergillosis, blastomycosis, chronic mucocutaneous candidiasis, and coccidioidomycosis amongst others in the USA. Sporanox's patents are valid until 2033-06-21 (FDA).
| Trade Name | Onmel, Sporanox, Tolsura |
|---|---|
| Common Name | Itraconazole |
| Indication | aids-related opportunistic infections, aspergillosis, blastomycosis, chronic mucocutaneous candidiasis, coccidioidomycosis, cryptococcosis, histoplasmosis, leishmaniasis, mycoses, neutropenia, onychomycosis, oral candidiasis, paracoccidioidomycosis, sporotrichosis, vulvovaginal candidiasis, zygomycosis |
| Drug Class | Systemic antifungals (miconazole type) |
